GMAB•benzinga•
Genmab Expects Its 2025 Operating Profit To Be In Range Of $0.9B-$1.4B; Expects Its 2025 Revenue To Be In Range Of $3.3B-$3.7B, Compared To $3.1B In 2024; Sees 2025 Operating Expenses To Be In Range Of $2.1B-$2.2B; Anticipates Its 2025 Operating Expenses
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 12, 2025 by benzinga